FDA approves new drug for patients with schizophrenia

The FDA has approved Caplyta for the treatment of schizophrenia in adults, according to a press release from the agent’s manufacturer. “We believe Caplyta provides health care providers a new, safe and effective treatment option to help the millions of adult patients with schizophrenia,” Sharon Mates, PhD, chairman and CEO of Intra-Cellular Therapies, said inContinue reading “FDA approves new drug for patients with schizophrenia”

Gluten Triggers Strange Delusions in Woman with Celiac Disease

By Sara G. Miller Gluten has been implicated in a number of symptoms related to celiac disease that go beyond the digestive system, including rashes, anemia and headaches. But according to a recent case report, the wheat protein played a role in one woman’s severe psychosis. The 37-year-old woman, whose case was described in theContinue reading “Gluten Triggers Strange Delusions in Woman with Celiac Disease”

Longer duration of untreated psychosis has now been linked to loss of brain volume

Longer duration of untreated psychosis was associated with accelerated hippocampal atrophy during initial antipsychotic treatment of first-episode schizophrenia, suggesting that psychosis may have persistent, negative effects on brain structure, according to finding published in JAMA Psychiatry. “Several factors … have been linked to early psychosis and could mediate an association between [duration of untreated psychosis]Continue reading “Longer duration of untreated psychosis has now been linked to loss of brain volume”

Taurine, a common additive to energy drinks, may help lessen the symptoms in first episode psychosis.

Supplementation with taurine, the additive found in many energy drinks, may improve the symptoms in young people suffering a first episode of psychosis (FEP), according to a new study presented at the International Early Psychosis Association (IEPA) meeting. Taurine, an amino acid naturally occurring in the body, exhibits an inhibitory neuro-modulatory effect in the nervousContinue reading “Taurine, a common additive to energy drinks, may help lessen the symptoms in first episode psychosis.”

Small RNA identified that offers clues for quieting the “voices” of schizophrenia

St. Jude Children’s Research Hospital scientists have linked disruption of a brain circuit associated with schizophrenia to an age-related decline in levels of a single microRNA in one brain region St. Jude Children’s Research Hospital scientists have identified a small RNA (microRNA) that may be essential to restoring normal function in a brain circuit associatedContinue reading “Small RNA identified that offers clues for quieting the “voices” of schizophrenia”

Computers can now accurately predict future development of schizophrenia based on how a person talks

A new study finds an algorithmic word analysis is flawless at determining whether a person will have a psychotic episode. by ADRIENNE LAFRANCE Although the language of thinking is deliberate—let me think, I have to do some thinking—the actual experience of having thoughts is often passive. Ideas pop up like dandelions; thoughts occur suddenly andContinue reading “Computers can now accurately predict future development of schizophrenia based on how a person talks”

Mystery surrounds hallucinatory chaos at German homeopathy conference

2C-E was one of the hundreds of drugs synthesised by Alexander Shulgin, who was known as the ‘godfather of ecstasy’. Photograph: Scott Houston/Corbis Police investigating a mass intoxication of a homeopathy conference in Germany with psychedelic drugs have said they still do not know nearly a week later whether it was an accident or anContinue reading “Mystery surrounds hallucinatory chaos at German homeopathy conference”

Computers are now able to predict who will develop psychosis years later based on analysis of their speech patterns.

An automated speech analysis program correctly differentiated between at-risk young people who developed psychosis over a two-and-a-half year period and those who did not. In a proof-of-principle study, researchers at Columbia University Medical Center, New York State Psychiatric Institute, and the IBM T. J. Watson Research Center found that the computerized analysis provided a moreContinue reading “Computers are now able to predict who will develop psychosis years later based on analysis of their speech patterns.”

Eye tests may predict schizophrenia

Schizophrenia is associated with structural and functional alterations of the visual system, including specific structural changes in the eye. Tracking such changes may provide new measures of risk for, and progression of the disease, according to a literature review published online in the journal Schizophrenia Research: Cognition, authored by researchers at New York Eye andContinue reading “Eye tests may predict schizophrenia”

Should psychedelics be declassified in order to examine their therapeutic potential in some forms of mental illness?

Psychedelics were highly popular hallucinogenic substances used for recreational purposes back in the 1950s and 1960s. They were also widely used for medical research looking into their beneficial impact on several psychiatric disorders, including anxiety and depression. In 1967, however, they were classified as a Class A, Schedule I substance and considered to be amongContinue reading “Should psychedelics be declassified in order to examine their therapeutic potential in some forms of mental illness?”